Cargando...
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
SIMPLE SUMMARY: Cancer onset and progression are promoted by high deregulation of the immune system. Recently, major advances in molecular and clinical cancer immunology have been achieved, offering new agents for the treatment of common tumors, often with astonishing benefits in terms of prolonged...
Guardado en:
| Publicado en: | Cancers (Basel) |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036682/ https://ncbi.nlm.nih.gov/pubmed/33808190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071587 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|